{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-116698","form_type":"8-K","ticker":"PYXS","cik":"0001782223","company_name":"Pyxis Oncology, Inc.","filed_at":"2024-10-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.591754+00:00","generated_at":"2026-05-30T11:08:20.950513+00:00","sec_items":["5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Pyxis Oncology shareholders approve 5.5M share increase in equity plan at special meeting","bullets":["Shareholders voted 23,234,250 to 12,829,636 to approve amendment to 2021 Equity and Incentive Plan adding 5,500,000 shares.","Proposal to adjourn if needed passed but was unnecessary; quorum of 36,189,305 shares present.","59,422,945 shares outstanding; special meeting held virtually on October 23, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-116698","json":"https://secwatch.observer/filing/0000950170-24-116698.json","markdown":"https://secwatch.observer/filing/0000950170-24-116698.md","text":"https://secwatch.observer/filing/0000950170-24-116698.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1782223/000095017024116698/0000950170-24-116698-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1782223/000095017024116698/pyxs-20241023.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T11:08:20.950513+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}